Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medical Health Institute vs MultiMedRx

Medical Health Institute
Graded #469

Lower grade

vs+4.300000000000004
MultiMedRx
Graded #393

Higher grade

The verdict

MultiMedRx takes it — 57.6/100 to 53.3/100.

MultiMedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MultiMedRx is a LegitScript-certified telehealth platform with physical offices in Newport Beach, CA and Reno, NV.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationMultiMedRx +13
40
53
Clinical oversightMultiMedRx +10
69
79
Labs & monitoringMultiMedRx +1
52
53
FulfillmentEven
67
67
Contract termsMedical Health Institute +6
55
49
Medical Health Institute · left barMultiMedRx · right bar

The numbers

MetricMedical Health InstituteMultiMedRx
WeighScore53.3/10057.6/100
GradeCC
Scorecard rank#469#393
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Medical Health Institute

Graded #469 · C

Strengths

  • Operating entity disclosed: Medical Health Institute, LLC, with full Pinecrest, FL address and phone
  • Named medical director (Amy Wecker, MD) plus four more named clinicians on the about page
  • Three care pathways with starting-price anchors: $99 TRT / $129 peptides / $149 weight-loss
  • LegitScript Certified with a footer verification link
  • HIPAA compliance claimed

Where it loses points

  • GLP-1 medication options (semaglutide vs tirzepatide; compounded vs brand) not shown — gated behind the intake funnel
  • Pharmacy partner not named — only generic 'FDA-regulated facilities' language
  • State availability not disclosed
  • Several subpages (/weight-loss, /pricing, /products, /faq) returned server errors during verification
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
MultiMedRx

Graded #393 · C

Strengths

  • Legal entity disclosed (MMRX MultiMedRx LLC) — uncommon transparency
  • Two physical addresses listed: Newport Beach, CA and Reno, NV
  • LegitScript seal present
  • Features brand-name GLP-1s (Ozempic, Wegovy, Zepbound) — rare in a mostly compounded-only field
  • Broader cardiometabolic menu (metformin, testosterone, HRT) alongside GLP-1

Where it loses points

  • No Mounjaro or Foundayo in the brand-name lineup (only Ozempic, Wegovy, Zepbound)
  • Monthly GLP-1 pricing isn't published — gated behind the consultation
  • $100 consultation fee adds friction; many peers bundle it into the medication price
  • Per-state availability not listed; only CA and NV offices disclosed
  • Whether compounded GLP-1 is offered isn't clear — verify during intake

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard